Hi Gass
My guess is that a lot of sentiment and money exited PAB and put there money elsewhere whilst PAB sort about correcting their e.run....
Now this has been achieved there has not been the ergancy to get back in with so many other hot plays out there..
In reality a lot waiting in the wings are looking at investing a lot closer to clinical trial time lines whichwill be around this time next year...
Who wants to tie their money up for another 9 months before a real turn in sentiment changes back in PAB's favour??
I am of the opinion that behind the scenes that the Dr and BoD are looking at licencing our IP's and to be in it whilst they broker these deals to gain maximum SP appreciations..
Yes it is strange why we have not broke 3c and stayed there but without being nearer to the clinic dates and Tox still being processed and starting next quarter it does leave time to make time to make your money work harder elswhere..
IMHO the Dr has to get this way over 10c to even start talking deals and this is only 50% higher than where we were a few years ago well before all the info we have available today...
We need(the Dr would know this,) to have Ann after Ann of positiveness not just the same old rehash to gain back sentiment and volume to get where he needs this to be to get the deals done at a price PAB is valued at in his mindset..
I personally think the run(rerating) will start next quarter and a build up of people wanting in will pressure up as talking clincal trials will help speed things up...
Sentiment will change soon and PAB will get the SP appreciation it warrants and big Pharma will have to step in at some point and not let the chance of PAB being bought by competitors if it is able to be destructive in the Cancer cure space..
There is a lot of exciting stuff coming and it is only time that will be the enemy if you let it get to you..
When this goes it will be very hard to bring it back down as there is nothing that can really stop this now going to clinic, the chance of any king of succses in the clinic is high and the SP will foloow suit in due course..
- Forums
- ASX - By Stock
- PAB
- Ann: CBCF funding to support deoxymab brain cancer development
Ann: CBCF funding to support deoxymab brain cancer development, page-26
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAB (ASX) to my watchlist
|
|||||
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M |
Open | High | Low | Value | Volume |
0.7¢ | 0.7¢ | 0.7¢ | $620 | 88.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
27 | 5809153 | 0.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.7¢ | 1618945 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
27 | 5809153 | 0.006 |
16 | 7030776 | 0.005 |
7 | 4425000 | 0.004 |
5 | 2730016 | 0.003 |
2 | 4520000 | 0.002 |
Price($) | Vol. | No. |
---|---|---|
0.007 | 1618945 | 3 |
0.008 | 2057547 | 3 |
0.009 | 133332 | 1 |
0.010 | 1592000 | 4 |
0.011 | 1080000 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
PAB (ASX) Chart |